Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.resp.2020.103489 http://scihub22266oqcxt.onion/10.1016/j.resp.2020.103489 32629100!7332943!32629100     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32629100&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Respir+Physiol+Neurobiol 2020 ; 280 (ä): 103489 Nephropedia Template TP {{tp|p=32629100|t=2020. Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 |pdf=|usr=}}{{32629100}} gab.com Text Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 JO: Respir Physiol Neurobiol http://www.kidney.de/pget.php?&tw=1&pmid=32629100 #FOAvip BACKGROUND: During the COVID-19 outbreak, a very high number of infected patients developed pneumonia and many of them complicated with acute respiratory distress syndrome. The optimal management of respiratory failure and the role of lung ultrasound imaging in the evaluation of efficacy of treatment are unknown. METHODS: In March 2020 we treated 18 patients with mild and moderate ARDS secondary to SARS-CoV-2 with non-invasive continuous positive airway pressure therapy (NI-CPAP). All patients underwent lung ultrasound imaging to verify the entity of lung recruitment after NI-CPAP initiation. RESULTS: After one hour of treatment we observed a significant improvement in PaO2/FiO2 ratio in 10 patients. Notably, only 50 % of them reached an effective improvement in lung aeration detectable with lung ultrasound. In the other 50 % or patients the improvement in PaO2/FiO2 might be related to blood redistribution and reverse of hypoxic vasoconstriction. CONCLUSION: NI- CPAP is a valid therapeutic option in mild and moderate ARDS secondary SARS-CoV-2. Lung recruitment detected by means of lung ultrasound is a relevant but not the exclusive mechanism that underlies the therapeutic efficacy of NI-CPAP in this clinical setting. Twit Text FOAVip Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 ????Respir Physiol Neurobiol http://www.kidney.de/pget.php?&tw=1&pmid=32629100 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32629100 #FOAvip English Wikipedia <ref>{{Cite pmid|32629100}}</ref> Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 #MMPMID32629100 Pagano A; Porta G; Bosso G; Allegorico E; Serra C; Dello Vicario F; Minerva V; Russo T; Altruda C; Arbo P; Mercurio V; Numis FG Respir Physiol Neurobiol 2020[Sep]; 280 (ä): 103489 PMID32629100show ga BACKGROUND: During the COVID-19 outbreak, a very high number of infected patients developed pneumonia and many of them complicated with acute respiratory distress syndrome. The optimal management of respiratory failure and the role of lung ultrasound imaging in the evaluation of efficacy of treatment are unknown. METHODS: In March 2020 we treated 18 patients with mild and moderate ARDS secondary to SARS-CoV-2 with non-invasive continuous positive airway pressure therapy (NI-CPAP). All patients underwent lung ultrasound imaging to verify the entity of lung recruitment after NI-CPAP initiation. RESULTS: After one hour of treatment we observed a significant improvement in PaO2/FiO2 ratio in 10 patients. Notably, only 50 % of them reached an effective improvement in lung aeration detectable with lung ultrasound. In the other 50 % or patients the improvement in PaO2/FiO2 might be related to blood redistribution and reverse of hypoxic vasoconstriction. CONCLUSION: NI- CPAP is a valid therapeutic option in mild and moderate ARDS secondary SARS-CoV-2. Lung recruitment detected by means of lung ultrasound is a relevant but not the exclusive mechanism that underlies the therapeutic efficacy of NI-CPAP in this clinical setting. |*Betacoronavirus[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19[MESH] |Continuous Positive Airway Pressure/*methods[MESH] |Coronavirus Infections/*complications/diagnostic imaging/*therapy[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/diagnostic imaging/*therapy[MESH] |Prospective Studies[MESH] |Respiratory Distress Syndrome/diagnostic imaging/*etiology/*therapy[MESH]Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing